314 related articles for article (PubMed ID: 31434983)
41. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
[TBL] [Abstract][Full Text] [Related]
42. Effect of IFN-γ on the kynurenine/tryptophan ratio in monolayer-cultured keratinocytes and a 3D reconstructed human epidermis model.
Gustafsson A; Prgomet Z; Jankovskaja S; Ruzgas T; Engblom J; Ohlsson L; Gjörloff Wingren A
J Dermatol Sci; 2020 Sep; 99(3):177-184. PubMed ID: 32782183
[TBL] [Abstract][Full Text] [Related]
43. UVB Radiation and Selected Tryptophan-Derived AhR Ligands-Potential Biological Interactions in Melanoma Cells.
Walczak K; Kazimierczak P; Szalast K; Plech T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299117
[TBL] [Abstract][Full Text] [Related]
44. Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice.
Tashita C; Hoshi M; Hirata A; Nakamoto K; Ando T; Hattori T; Yamamoto Y; Tezuka H; Tomita H; Hara A; Saito K
World J Gastroenterol; 2020 Mar; 26(9):918-932. PubMed ID: 32206003
[TBL] [Abstract][Full Text] [Related]
45. Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells.
Chen YC; He XL; Qi L; Shi W; Yuan LW; Huang MY; Xu YL; Chen X; Gu L; Zhang LL; Lu JJ
Biochem Pharmacol; 2022 Mar; 197():114940. PubMed ID: 35120895
[TBL] [Abstract][Full Text] [Related]
46. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
[TBL] [Abstract][Full Text] [Related]
47. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases.
Boros FA; Bohár Z; Vécsei L
Mutat Res Rev Mutat Res; 2018; 776():32-45. PubMed ID: 29807576
[TBL] [Abstract][Full Text] [Related]
48. Investigation of indoleamine 2,3-dioxygenase 1 expression in uveal melanoma.
Liang C; Peng L; Zeng S; Zhao Q; Tang L; Jiang X; Zhang J; Yan N; Chen Y
Exp Eye Res; 2019 Apr; 181():112-119. PubMed ID: 30639792
[TBL] [Abstract][Full Text] [Related]
49. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
Bonanno G; Mariotti A; Procoli A; Folgiero V; Natale D; De Rosa L; Majolino I; Novarese L; Rocci A; Gambella M; Ciciarello M; Scambia G; Palumbo A; Locatelli F; De Cristofaro R; Rutella S
J Transl Med; 2012 Dec; 10():247. PubMed ID: 23232072
[TBL] [Abstract][Full Text] [Related]
50. Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.
Oxenkrug G; van der Hart M; Roeser J; Summergrad P
Integr Clin Med; 2017; 1(1):. PubMed ID: 28748226
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
[TBL] [Abstract][Full Text] [Related]
52. Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines.
Weber WP; Feder-Mengus C; Chiarugi A; Rosenthal R; Reschner A; Schumacher R; Zajac P; Misteli H; Frey DM; Oertli D; Heberer M; Spagnoli GC
Eur J Immunol; 2006 Feb; 36(2):296-304. PubMed ID: 16385630
[TBL] [Abstract][Full Text] [Related]
53. High expression of IDO1 and TGF-β1 during recurrence and post infection clearance with Chlamydia trachomatis, are independent of host IFN-γ response.
Ziklo N; Huston WM; Taing K; Timms P
BMC Infect Dis; 2019 Mar; 19(1):218. PubMed ID: 30832593
[TBL] [Abstract][Full Text] [Related]
54. Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
Spranger S; Spaapen RM; Zha Y; Williams J; Meng Y; Ha TT; Gajewski TF
Sci Transl Med; 2013 Aug; 5(200):200ra116. PubMed ID: 23986400
[TBL] [Abstract][Full Text] [Related]
55. Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease.
Mazarei G; Leavitt BR
J Huntingtons Dis; 2015; 4(2):109-18. PubMed ID: 26397892
[TBL] [Abstract][Full Text] [Related]
56. Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer.
Nguyen DJM; Theodoropoulos G; Li YY; Wu C; Sha W; Feun LG; Lampidis TJ; Savaraj N; Wangpaichitr M
Mol Cancer Res; 2020 Jan; 18(1):105-117. PubMed ID: 31628200
[TBL] [Abstract][Full Text] [Related]
57. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
58. The Role of Kynurenines Produced by Indolamine-2,3-Dioxygenase 1 in Sepsis.
Lerch S; Schefold JC; Spinetti T
Pharmacology; 2022; 107(7-8):359-367. PubMed ID: 35413710
[TBL] [Abstract][Full Text] [Related]
59. Bisphenol F exposure induces depression-like changes: Roles of the kynurenine metabolic pathway along the "liver-brain" axis.
Yu Z; Lin Y; Wu L; Wang L; Fan Y; Xu L; Zhang L; Wu W; Tao J; Huan F; Liu W; Wang J; Gao R
Environ Pollut; 2024 Apr; 346():123356. PubMed ID: 38266696
[TBL] [Abstract][Full Text] [Related]
60. The immune-kynurenine pathway in social anxiety disorder.
Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]